A Brief Introduction to Nerve Agents

Please use this identifier to cite or link to this item:
https://osnadocs.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202103034076
Open Access logo originally created by the Public Library of Science (PLoS)
Full metadata record
DC FieldValueLanguage
dc.creatorSaalbach, Klaus-
dc.date.accessioned2021-03-03T08:02:59Z-
dc.date.available2021-03-03T08:02:59Z-
dc.date.issued2021-03-03T08:03:00Z-
dc.identifier.citationSaalbach, Klaus: [Arbeitspapier] A Brief Introduction to Nerve Agents. Universität Osnabrück, 2021ger
dc.identifier.urihttps://repositorium.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202103034076-
dc.description.abstractIn security policy, nerve agents are a relevant threat in chemical warfare, but also for attacks on individuals. The aim of this introduction is to provide basic historical, legal, medical and chemical knowledge of this complex matter for everyone who is interested in security policy and chemical warfare and to increase awareness. In the previous decade, attacks with the nerve agents sarin, VX and Novichok were reported. The weaponized nerve agents belong to the chemical group of organophosphates with four generations which block the enzyme acetylcholinesterase leading to a large variety of symptoms: The G-series, the V-series, the A-series (Novichoks) and the carbamates which are however currently not weaponized. The first chapter explains the mode of action and biochemical properties, then the history and the legal framework of the Chemical Weapons Convention. Thereafter, the symptoms and countermeasures are presented. The course of the resulting disease depends on the type of agent, the extent of exposure and the speed of therapeutic intervention. Rapid diagnosis and treatment are needed to limit damage and to prevent death, but also due to a chemical ‘aging’ process of the affected enzyme. The medical treatment of nerve agents is embedded into other measures like physical protection, decontamination and triage and includes the imminent pre-hospital and the hospital treatment phases. The treatment is based on anticholinergics (atropine), acetylcholinesterase reactivation by oximes, anticonvulsive therapy with benzodiazepines and respiratory support to prevent respiratory failure as primary cause of death. New therapeutic concepts like bioscavengers are briefly discussed and summarized.eng
dc.rightsAttribution 3.0 Germany*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/*
dc.subjectChemical Warfareeng
dc.subjectSecurity Policyeng
dc.subjectNerve Agentseng
dc.subject.ddc320 - Politikger
dc.subject.ddc610 - Medizin, Gesundheitger
dc.subject.ddc540 - Chemieger
dc.titleA Brief Introduction to Nerve Agentseng
dc.typeArbeitspapier [workingPaper]ger
Appears in Collections:FB01 - Hochschulschriften

Files in This Item:
File Description SizeFormat 
Nerve_Agents_27_Feb_2021_Saalbach.pdfWorking Paper380,01 kBAdobe PDF
Nerve_Agents_27_Feb_2021_Saalbach.pdf
Thumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons